Fundraising FoxKate Therapeutics
San Diego, US · Founded 2020 · Delaware corporation · 5 known investors
Find your way into Kate Therapeutics
Sign up to see every warm intro you have to Kate Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kate Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
Investors · 5
How we know: oup.vc · Not right? Tell us
How we know: Westlake Village BioPartners's portfolio page · funding news · prnewswire.com · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: a partner's Signal profile · funding news · prnewswire.com · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements$123.8M disclosed across 4 rounds · 2021–2024
- $51MSeries AJun 2023 · 3 sources
Versant Ventures (lead), Westlake Village BioPartners (lead), Osage University Partners, UF Innovate | Ventures
Source ↗
▶$16MraisedAug 2024 · 1 investors · BiotechnologyRule 506(b)
- Clare Ozawa, Ph.D.Director
- Kevin Forrest, Ph.D.Executive Officer, Director
- Beth Seidenberg, M.D.Director
- Offering amount
- $16M
- Amount sold
- $16M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$21.8MraisedAug 2024 · 8 investors · BiotechnologyRule 506(b)
- Clare Ozawa, Ph.D.Director
- Kevin Forrest, Ph.D.Executive Officer, Director
- Beth Seidenberg, M.D.Director
- Offering amount
- $23.4M
- Amount sold
- $21.8M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$35MraisedAug 2024 · 5 investors · BiotechnologyRule 506(b)
- Kevin Forrest, Ph.D.Executive Officer, Director
- Clare Ozawa, Ph.D.Director
- Beth Seidenberg, M.D.Director
- Offering amount
- $35M
- Amount sold
- $35M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Kate Therapeutics's investors?
- Kate Therapeutics's investors include OUP (Osage University Partners), Westlake Village BioPartners, Kleiner Perkins, Versant Ventures.
- How much funding has Kate Therapeutics raised?
- Kate Therapeutics has disclosed $123.8M raised across 4 rounds.
- Where is Kate Therapeutics headquartered?
- Kate Therapeutics is headquartered in San Diego, US.